Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income (loss)	$ 1,273,783	$ (2,139,000)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	2,232,509	202,000
Amortization of right-of-use assets	521,774	0
Amortization of deferred financing costs	591,357	0
Stock-based compensation expense	516,800	979,000
Accretion of fair value liability	125,398	0
Net gain on sale of subsidiary	(82,894)	0
Imputed interest for note payable	10,006
Loss contingency on equity issuance	301,350	0
Loss on early termination of operating lease	202,150	3,000
Loss (gain) on derivative liabilities	942,390	(12,000)
Tax provision on income	162,368	0
Provision (reversal) for bad debt	61,671	(69,000)
Change in operating assets and liabilities:
Accounts receivable	(5,614,459)	(580,000)
Contract assets	(85,282)	0
Prepaid expenses	(1,112,772)	45,000
Accounts payable and accrued expenses	6,837,288	(969,000)
Other assets	(787,900)	(68,000)
Operating lease liability	(583,058)	(222,000)
Due to related parties	0	(34,000)
Contract liabilities	(267,420)	771,000
Other long term liabilities	177,271	(168,000)
Net cash provided by (used in) operating activities	5,422,330	(2,261,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash received for sale of Mission UK	(1,185)	0
Purchase of property and equipment	(170,851)	(68,000)
Net cash used in investing activities	(172,036)	(68,000)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Payments made for loss contingency on equity issuance	(3,615,000)	0
Principal payments made for bank loan	(956,250)	0
Payments for note payable to related party	(40,000)	(20,000)
Net cash used in financing activities	(4,611,250)	(20,000)
Effect of exchange rate on cash	(646,002)	35,000
NET DECREASE IN CASH AND CASH EQUIVALENTS	(6,958)	(2,314,000)
CASH AND CASH EQUIVALENTS — beginning of period	32,673,801	12,066,000
CASH AND CASH EQUIVALENTS — end of period	32,666,843	9,752,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest expense	2,077,285	3,000
Noncash investing and financing activities:
Right-of-use assets acquired through adoption of ASC 842	0	467,000
Conversion of preferred stock	$ 274,237	$ 0